Epidemiology of Dementias

Slides:



Advertisements
Similar presentations
What can we learn from people with Alzheimer’s disease? Professor Bob Woods Dementia Services Development Centre Wales Bangor University.
Advertisements

APOE Genotype Effects on Alzheimer’s Disease Clinical Onset, Epidemiology, and Gompertzian Aging Functions J.Wesson Ashford, M.D., Ph.D. Stanford / VA.
Determining capacity and protecting subjects who have lost capacity Jason Karlawish, MD University of Pennsylvania.
Journal Club Alcohol and Health: Current Evidence September–October 2004.
Mild Cognitive Impairment
MCI Clinical Trial Design FDA Advisory Committee Meeting March 13, 2001 Gaithersburg, MD Michael Grundman, MD, MPH Alzheimer’s Disease Cooperative Study.
Nikki Jandt Denise Halbach Tearanie VanBoxel Life Cycle Nutrition
Gender Difference in Alzheimer’s Disease Neuropathology EH Corder, E Ghebremedhin, M Taylor, DR Thal, TG Ohm, H Braak Dr. Senckenbergische Anatomie Department.
ADRC Training1 Meeting the Needs of Aging Persons with Developmental Disabilities Cross Network Collaboration for Florida Bridging the Networks - Needs.
Epidemiology of Dementia: the MoVIES Project Alzheimer’s Disease Patient Registry (ADPR ), University of Pittsburgh Initially funded by NIA under.
CI-1 Exelon ® (rivastigmine) United States Food and Drug Administration Peripheral and Central Nervous System Drugs Advisory Committee May 17, 2006.
Canadian Study of Health and Aging The Incidence and Progression of Dementia 1996 Follow-Up Study.
CHP400: Community Health Program- lI Research Methodology STUDY DESIGNS Observational / Analytical Studies Case Control Studies Present: Disease Past:
Defining Mild Cognitive Impairment Steven T.DeKosky, M.D. Director, Alzheimer’s Disease Research Center University of Pittsburgh Pittsburgh, PA.
Androgen Therapy for Low Sexual Desire: A Concerned Physician’s View James A. Simon, M.D. Clinical Professor George Washington University Washington, DC.
ASSESSMENT OF QUALITY OF LIFE IN DEMENTIA: problems, methods and results Michel Ylieff Michel Ylieff Qualidem Research Group University of Liege (ULg)
CHAPTER 23: Neurological Disorders in Women. Introduction Gender differences exist in the development and expression of several neurological disorders,
Dementia: Delivering the Diagnosis Daniel D. Christensen, M.D. Clinical Professor of Psychiatry Clinical Professor of Neurology Adjunct Professor of Pharmacology.
Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Chapter 33 Delirium and Dementia.
Alzheimer’s Disease  Goals  To understand what dementia is  To explore causes, risk factors, symptoms, and treatments of Alzheimer’s Disease  To better.
Detecting Individual Differences in Changes in Memory Functioning Dr. Len Lecci Professor of Psychology University of North Carolina Wilmington Director.
Adverse Outcomes After Hospitalization and Delirium in Persons with Alzheimer Disease Charles Wang, PharmD Candidate.
PZP: A novel biomarker for early Alzheimer’s disease ? Diana A.T. Nijholt Department of Neurology Laboratory for Clinical and Cancer Proteomics
Peripheral and Central Nervous System Drugs Advisory Committee Meeting - March 14, Issues Related to the Development of Drugs for the Treatment.
Isolation and emotional wellbeing Dr James Warner CNWL Foundation Trust.
Dementia: Alzheimer’s Disease Cyril Evbuomwan Patient Group Meeting 1 st December 2015.
Cognitive Disorders Chapter 13 Nature of Cognitive Disorders: An Overview Perspectives on Cognitive Disorders Cognitive processes such as learning, memory,
The Alzheimer’s Disease Challenge: Take Your Knowledge Further ALZHEIMER’S DISEASE AND ITS MANAGEMENT: AN OVERVIEW.
Cognitive Disorders Delirium, Dementia, Amnestic Disorders.
Dementia F.Etessam. MD. Dementia A progressive impairment of cognitive functions occurring in clear consciousness.
Dementia Jaqueline Raetz, M.D.. Types of Dementia Alzheimer Dementia 70% Lewy Body Dementia about 22% Vascular Dementia 17% Frontotemporal Dementia Overall.
Epidemiology of Dementia in Rochester, Minnesota
Aka STEEL VALLEY SENIORS SURVEY (SVSS)
59 year old man w visual hallucinations
Bilingualism or multilingualism has protective effect on dementia onset: is there any evidence? A systematic review Yadav AK, Yadav J, Kumar P, Sagar R,
Present: Disease Past: Exposure
Joe Verghese, MBBS, MS. Translating Insights from
Learn about different types of diabetes
Epidemiology: Assignment 3
Changing demographics and the impact on dementia
Effect of centrally acting ACE inhibitors on Alzheimer’s disease progress: A retrospective longitudinal study using SLAM BRC Case register Dr Gayan Perera.
Presentation for the SCTR Scientific Retreat on Aging Related Research
Epidemiology of Dementia: the MoVIES Project
Neural.
Seizures in Alzheimer’s disease
2014 Alzheimer's disease facts and figures
BIOMEDICAL RESEARCH.
Dementia Risk Prediction Development of the first tool for LMICs (WS2)
Cognitive Disorders and Aging
Dementia risk model validation in low and middle income countries
By Michelle Liu, Senior data analyst interRAI
Figure 1 Hypothetical staging model of sporadic Alzheimer disease (AD)
Assessing and Modifying Risks for Older Drivers
Early Dementia Distinguishing AD From MCI
Chapter 30 Delirium and Dementia
Prevalence of statin and beta-blocker use by clinical presentation
Dementia and TBI.
Summer School on Neuroscience & Aging
Chapter 93 Dementias and Related Disorders
Assessment of BPSD Rajesh Tampi , MD Professor of Psychiatry
Introduction to AD. Practical Approaches to the Identification of Alzheimer Disease in Primary Care.
Epidemiology of Dementia in Rochester, Minnesota
Baseline Characteristics of the Subjects
Occurrence of falls in the past year on the basis of the set of risk factors (poor self rated health, poor cognitive status, impaired ADL, two or more.
The Memory Assessment and Treatment Service (MATS)
Chapter 25 The Elderly.
2014 Alzheimer's disease facts and figures
Interreg-IPA Cross-border Cooperation Programme Romania-Serbia
Hazard risks for incident dementia by diverse social relationship engagement score. The scores are calculated by adding the number of selected social relationship.
Presentation transcript:

Epidemiology of Dementias Gerald van Belle Biostatistics and ADRC University of Washington

Outline Definition of dementia, AD Prevalence and incidence Risk factors (including protective) Assessing disease progression Why is AD research so hard? Summary

Definitions Dementia: original meaning madness Current meaning: “…global, non-reversible impairment of cerebral function with preservation of clear consciousness. It usually results in loss of memory…executive function…changes in personality.” (BMJ/CE).

Definitions Alzheimer’s disease “…insidious onset...slow deterioration…may be diagnosed after other systemic and neurological causes of dementia have been excluded clinically and by laboratory investigation.” (BMJ/CE).

Prevalence of AD South Carolina Study (Laditka et al, 2004) Rate per 1000 Age 55-64 65-84 85+ Men 3 43 338 Women 3 33 299 Eur. Am. 2 33 293 Afr. Am. 6 65 436

Prevalence of Dementia— Jorm Model Rate per 1000 person years Age Model 65-69 14 70-74 28 75-79 56 80-84 105 85-89 208 90+ 386

Incidence of Dementia Kukull et al (2002) Rate per 1000 person years Age Dementia AD 65-69 5 4 70-74 10 6 75-79 14 9 80-84 38 30 85-89 59 46 90+ 89 61

Incidence of Dementia— Jorm-like Model Rate per 1000 person years Age Model 65-69 5 70-74 8 75-79 15 80-84 28 85-89 51 90+ 93

“Risk” Factors for AD Genetic/familial Environmental Cultural Medical Other categories? Subject of lots of research

Assessing Disease Progression Activity of daily living Cognitive assessment Clinical/caregiver setting (ADL is key) Research setting (Cognitive enters) Clinical trials Disease modeling Risk factor assessment

Why is AD Research so Hard? Diagnosis by exclusion Gold standard (neuropath) is tarnished Treatments are palliative Cognitive tests are biased Slow disease progression Inability of subject to contribute detailed information Competing risks

Summary Prevalence of dementia doubles every five years. Rate at age 65 about 1 per 100 Approximately 70% of dementia is AD Very few disease-specific risk factors Disease progression research focuses on cognition AD has unique aspects